Autotaxin inhibitor successful in the first trial in diffuse cutaneous systemic sclerosis Presented ByProf. Dinesh Khanna, University of Michigan Scleroderma Program, USA TrialPhase 2, NOVESA ConferenceACR 2020 18 January, 2021 11:02